Cigarette smoking augments sympathetic nerve activity in patients with coronary heart disease

International Heart Journal

Volumn 49, Issue 3, 2008, Pages 261-272

  Shinozaki, Norihiko ^a   Yuasa, Toyoshi ^b   Takata, Shigeo ^c  

^a Naganoken Koseiren Shinonoi General Hospital   (Japan)

^b Public Central Hospital of Matto Ishikawa   (Japan)

^c Kanazawa University   (Japan)

Author keywords

Angina pectoris; Baroreflex sensitivity; Cigarette smoking; Coronary artery disease; Muscle sympathetic nerve activity; Nicotine; Sympathetic activity

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NICOTINE; NITRATE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION FUNCTION; DIASTOLIC BLOOD PRESSURE; FOREARM BLOOD FLOW; HEART INNERVATION; HEART RATE; HUMAN; HYPOTHESIS; ISCHEMIC HEART DISEASE; MALE; PATHOGENESIS; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

ADULT; AGED; BAROREFLEX; BLOOD PRESSURE; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FOREARM; HEART RATE; HUMANS; MALE; MIDDLE AGED; NICOTINE; REGIONAL BLOOD FLOW; SMOKING; SYMPATHETIC NERVOUS SYSTEM;

EID: 49449083192     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.261     Document Type: Article

References (51)

1. The Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: Final report of the pooling project, J Chron Dis 1978; 31: 201-306.
2. Wilhelmsen L. Coronary, heart disease: epidemiology of smoking and intervention studies of smoking, Am Heart J 1988; 115: 242-9.
3. Kannel WB, Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. J Hypertens 1990; 8: S3-8.
4. Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation 2005; 112: 489-97.
5. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 2006; 368: 647-58.
6. Baer L, Radichevich I. Cigarette smoking in hypertensive patients. Blood pressure and endocrine responses. Am J Med 1985; 78: 564-8.
7. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976; 295: 573-7.
8. Trap-Jensen J, Carlen JE, Svendsen TL, Christensen NJ. Cardiovascular and adrenergic effects of cigarette smoking during immediate non-selective and selective beta adrenoceptor blockade in humans. Eur J Clin Invest 1979; 9: 181-3.
9. Auerbach O, Hammond EC, Garfinkel L. Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med 1965; 273: 775-9.
10. Klein LW, Ambrose J, Pichard A, Holt J, Gorlin R, Teichholz LE. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. J Am Coll Cardiol 1984; 3: 879-86.
11. Winniford MD, Wheelan KR, Kremers MS, et al. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986; 73: 662-7.
12. Deanfield JE, Shea MJ, Wilson RA, Horlock P, de Landsheere CM, Selwyn AP. Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow. Am J Cardiol 1986; 57: 1005-9.
13. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76-9.
14. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994; 330: 454-9.
15. Zeiher AM, Schächinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92: 1094-100.
16. Lekakis J, Papamichael C, Vemmos C, et al. Effect of acute cigarette smoking on endothelium-dependent brachial artery dilatation in healthy individuals. Am J Cardiol 1997; 79: 529-31.
17. Neunteufl T, Heher S, Kostner K, et al. Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol 2002; 39: 251-6.
18. Yasue H, Hirai N, Mizuno Y, et al. Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J 2006; 70: 8-13.
19. Tanriverdi H, Evrengul H, Kuru O, et al. Cigarette smoking induced oxidative stress may impair endothelial function and coronary blood flow in angiographically normal coronary arteries. Circ J 2006; 70: 593-9.
20. Benowitz NL. Nicotine and coronary heart disease. Trends Cardiovasc Med 1991; 1: 315-21.
21. Benowitz NL. Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988; 17: 1318-30.
22. Groppelli A, Omboni S, Parati G. Blood pressure and heart rate response to repeated smoking before and after beta-blockade and selective alpha 1 inhibition. J Hypertens Suppl 1990; 8: S35-40.
23. Groppelli A, Giorgi DM, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992; 10: 495-9.
24. Trap-Jensen J. Effects of smoking on the heart and peripheral circulation. Am Heart J 1988; 115: 263-7.
25. Grassi G, Seravalle G; Calhoun DA, et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90: 248-53.
26. Narkiewicz K, van de Borne PJ, Hausberg M, et al. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998; 98: 528-34.
27. Goldstein DS, Feuerstein G; Izzo JL Jr, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981; 28: 467-75.
28. Jacob P 3rd, Yu L, Wilson M, Benowitz NL. Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3′, 3′ -d2 in humans. Biol Mass Spectrom 1991; 20: 247-52.
29. Hagbarth KE, Vallbo AB. Pulse and respiratory grouping of sympathetic impulses in human muscle nerves. Acta Physiol Scand 1968; 74: 96-108.
30. Delius W, Hagbarth KE, Hongell A, Wallin BG. General characteristics of sympathetic activity in human muscle nerves. Acta Physiol Scand 1972; 84: 65-81.
31. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 1988; 78: 816-24.
32. Haass M, Kübler W. Nicotine and sympathetic neurotransmission. Cardiovasc Drugs Ther 1997; 10: 657-65.
33. Karlin A. Structure of nicotinic acethylcholine receptors. Curr Opin Neurobiol 1993; 3: 299-309.
34. Unwin N. Neurotransmitter action: opening of ligand-gated ion channels. Cell 1993; 72 (Suppl): 31-41.
35. Armitage AK, Hall GH. Further evidence relating to the mode of action of nicotine in the central nervous system. Nature 1967; 214: 977-9.
36. Robertson D, Tseng CJ, Appalsamy M. Smoking and mechanisms of cardiovascular control. Am Heart J 1988; 115: 258-63.
37. Brezenoff HE, Jenden DJ. Changes in arterial blood pressure after microinjections of charbalol into the medulla and IVth ventricle of the rat brain. Neuropharmacology 1970; 9: 340-8.
38. Tseng CJ, Appalsamy M, Robertson D. Nicotine elicits hypertension in the ventral lateral medulla of the rat. Pharmacologist 1987; 29: 115-20.
39. Mancia G, Groppelli A, Di Rienzo M, Castiglioni P, Parati G. Smoking impairs baroreflex sensitivity in humans. Am J Physiol 1997; 273: H1555-60.
40. Gerhardt U, Vorneweg P, Riedasch M, Hohage H. Acute and persistent effects of smoking on the baroreceptor function. J Auton Pharmacol 1999; 19: 105-8.
41. Gordon T, Kannel WB, McGee D, Dawber TR. Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet 1974; 2: 1345-8.
42. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986; 314: 271-5.
43. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation 1997; 96: 1089-96.
44. Kinjo K, Sato H, Sakata Y, et al. Impact of smoking status on long-term mortality in patients with acute myocardial infarction. Circ J 2005; 69: 7-12.
45. Grassi G, Cattaneo BM, Seravalle G, et al. Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation 1997; 96: 1173-9.
46. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol 1996; 27: 358-64.
47. James MA, Rakicka H, Panerai RB, Potter JF. Baroreflex sensitivity changes with calcium antagonist therapy in elderly subjects with isolated systolic hypertension. J Hum Hypertens 1999; 13: 87-95.
48. Murzenok PP, Huang BS, Leenen FH. Sympathoinhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension 2000; 35: 631-6.
49. Leenen FH, Ruzicka M, Huang BS. Central sympathoinhibitory effects of calcium channel blockers. Curr Hypertens Rep 2001; 3: 314-21.
50. Ebert TJ, Morgan BJ, Barney JA, Denahan T, Smith JJ. Effects of aging on baroreflex regulation of sympathetic activity in humans. Am J Physiol 1992; 263: H798-803.
51. Huggett RJ, Scott EM, Gilbey SC, Stoker JB, Mackintosh AF, Mary DA. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003; 108: 3097-101.